Australia markets open in 7 hours 35 minutes

Sutro Biopharma, Inc. (STRO)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
3.4550-0.0650 (-1.85%)
As of 12:23PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts991010
Avg. Estimate-0.92-0.74-3.3-3.26
Low estimate-1.09-1.08-4.33-5.05
High estimate-0.72-0.03-0.76-0.74
Year ago EPS-0.85-0.64-1.78-3.3
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts9998
Avg. Estimate11.92M22.51M55.83M73.54M
Low estimate5M5.2M24M24M
High estimate24.65M69.27M129.61M204.86M
Year ago sales12.67M10.41M153.73M55.83M
Sales growth (year/est)-5.90%116.20%-63.70%31.70%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.81-0.73-0.74-0.82
Actual EPS-0.85-0.64-0.810.52
Difference-0.040.09-0.071.34
Surprise %-4.90%12.30%-9.50%163.40%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.92-0.74-3.3-3.26
7 days ago-0.92-0.74-3.3-3.26
30 days ago-0.94-0.95-3.93-3.77
60 days ago-0.86-0.84-3.44-3.27
90 days ago-0.86-0.84-3.44-3.27
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days1242
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesSTROIndustrySector(s)S&P 500
Current qtr.-8.20%N/AN/AN/A
Next qtr.-15.60%N/AN/AN/A
Current year-85.40%N/AN/AN/A
Next year1.20%N/AN/AN/A
Next 5 years (per annum)-12.88%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A